NYSE - Delayed Quote • USD
agilon health, inc. (AGL)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 5:29 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,866,405.00
4,316,363.00
2,388,220.00
1,521,494.00
1,218,333.00
Cost of Revenue
4,794,770.00
4,246,693.00
2,276,860.00
1,455,750.00
1,124,183.00
Gross Profit
71,635.00
69,670.00
111,360.00
65,744.00
94,150.00
Operating Expense
311,363.00
301,803.00
216,738.00
437,986.00
150,823.00
Operating Income
-239,728.00
-232,133.00
-105,378.00
-372,242.00
-56,673.00
Net Non Operating Interest Income Expense
-6,449.00
-6,658.00
-4,484.00
-6,146.00
-8,135.00
Other Income Expense
46,637.00
44,329.00
19,192.00
-4,588.00
2,465.00
Pretax Income
-199,540.00
-194,462.00
-90,670.00
-382,976.00
-62,343.00
Tax Provision
2,417.00
791.00
1,640.00
886.00
865.00
Net Income Common Stockholders
-284,682.00
-262,596.00
-106,553.00
-406,487.00
-60,052.00
Diluted NI Available to Com Stockholders
-284,682.00
-262,596.00
-106,553.00
-406,487.00
-60,052.00
Basic EPS
-0.69
-0.64
-0.26
-1.09
-0.16
Diluted EPS
-0.69
-0.64
-0.26
-1.09
-0.16
Basic Average Shares
407,867.50
408,917.00
408,154.00
372,931.00
384,836.39
Diluted Average Shares
407,867.50
408,917.00
408,154.00
372,931.00
384,836.39
Total Operating Income as Reported
-239,728.00
-232,133.00
-105,378.00
-372,242.00
-56,673.00
Total Expenses
5,106,133.00
4,548,496.00
2,493,598.00
1,893,736.00
1,275,006.00
Net Income from Continuing & Discontinued Operation
-284,682.00
-262,596.00
-106,553.00
-406,487.00
-60,052.00
Normalized Income
-201,843.00
-195,046.00
-87,687.18
-383,562.00
-63,208.00
Interest Expense
6,449.00
6,658.00
4,484.00
6,146.00
8,135.00
Net Interest Income
-6,449.00
-6,658.00
-4,484.00
-6,146.00
-8,135.00
EBIT
-193,091.00
-187,804.00
-86,186.00
-376,830.00
-54,208.00
EBITDA
-171,275.00
-167,643.00
-72,414.00
-362,160.00
-40,109.00
Reconciled Cost of Revenue
4,791,887.00
4,242,575.00
2,272,037.00
1,451,564.00
1,123,615.00
Reconciled Depreciation
21,816.00
20,161.00
13,772.00
14,670.00
14,099.00
Net Income from Continuing Operation Net Minority Interest
-201,843.00
-195,046.00
-91,999.00
-383,562.00
-63,208.00
Total Unusual Items Excluding Goodwill
--
--
-5,458.00
--
--
Total Unusual Items
--
--
-5,458.00
--
--
Normalized EBITDA
-171,275.00
-167,643.00
-66,956.00
-362,160.00
-40,109.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
-1,146.18
--
--
12/31/2020 - 4/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LFST LifeStance Health Group, Inc.
5.65
-2.59%
AMN AMN Healthcare Services, Inc.
54.21
+0.46%
ACHC Acadia Healthcare Company, Inc.
69.42
-3.29%
SGRY Surgery Partners, Inc.
25.46
-1.81%
CCM Concord Medical Services Holdings Limited
0.6914
-28.74%
PIII P3 Health Partners Inc.
0.5600
+2.55%
DCGO DocGo Inc.
3.1100
-3.42%
AONC American Oncology Network, Inc.
2.1400
+25.88%
TOI The Oncology Institute, Inc.
0.4500
0.00%
FMS Fresenius Medical Care AG
21.33
-0.37%